PALISADE BIO, INC. Other Non-Current Assets
PALISADE BIO, INC. (PALI) had Other Non-Current Assets of $0 as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-10
- 2026-06-30: Other Assets, Noncurrent $0.00.
- 2026-03-31: Other Assets, Noncurrent $17.00K.
- 2025-12-31: Other Assets, Noncurrent $68.00K.
- 2025-09-30: Other Assets, Noncurrent $119.00K.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $17.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $68.00K 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $119.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $171.00K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $222.00K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $273.00K 10-K · filed 2026-03-20 | |
| 2024-09-30 | $324.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $387.00K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $438.00K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $490.00K 10-K · filed 2025-03-24 | |
| 2023-09-30 | $438.00K 10-Q · filed 2024-05-13 | $541.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $592.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $643.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $694.00K 10-K · filed 2024-03-26 | |
| 2022-09-30 | $746.00K 10-Q · filed 2022-11-14 | |
| 2021-12-31 | $868.00K 10-K · filed 2023-03-22 | |
| 2019-06-30 | $36.90K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $53.35K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $23.96K 10-Q · filed 2019-08-14 | |
| 2018-09-30 | $28.48K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $33.00K 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $18.05K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $13.85K 10-K · filed 2019-03-22 | |
| 2017-09-30 | $13.72K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $13.70K 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $15.82K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $15.66K 10-K · filed 2018-04-02 | |
| 2016-09-30 | $49.98K 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $57.92K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $57.69K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $71.80K 10-K · filed 2017-03-23 | |
| 2015-09-30 | $72.16K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $57.26K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $59.10K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $58.71K 10-K · filed 2016-03-14 | |
| 2014-09-30 | $57.72K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $58.86K 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $64.85K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $64.90K 10-K · filed 2015-03-16 | |
| 2013-09-30 | $64.86K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $59.57K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $59.57K 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $59.57K 10-K · filed 2014-03-10 | |
| 2012-09-30 | $59.53K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $59.06K 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $75.39K 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $75.39K 10-K · filed 2013-03-15 | |
| 2011-09-30 | $68.66K 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $68.65K 10-Q/A · filed 2011-09-23 | |
| 2010-12-31 | $60.88K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |